Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Growth Rank : 4 (As of Dec. 14, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Growth Rank?

Zhejiang East-Asia Pharmaceutical Co has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Zhejiang East-Asia Pharmaceutical Co's Growth Rank

For the Biotechnology subindustry, Zhejiang East-Asia Pharmaceutical Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang East-Asia Pharmaceutical Co's Growth Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang East-Asia Pharmaceutical Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Zhejiang East-Asia Pharmaceutical Co's Growth Rank falls into.

Zhejiang East-Asia Pharmaceutical Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Zhejiang East-Asia Pharmaceutical Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang East-Asia Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Laodong North Road, 23rd Floor, General Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN

Website

http://www.eapharm.cn

Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co Headlines

No Headlines